FocalTherics
FOCL Healthcare Medical Distribution
FocalTherics' revenue for fiscal 2025 (year ended December 2025) was $70.5 million, up 1.63% from fiscal 2024. In the quarter to June 2026, revenue grew 38.9%, EPS fell 129.4%, free cash flow grew 21.5% and total debt rose 366.8%, each against the same quarter a year earlier. Revenue growth for five consecutive years; insiders bought in the last twelve months.
Follow FOCL
FocalTherics (FOCL) Altman Z-score
FocalTherics's Altman Z-score for fiscal 2025 is −0.87, in the distress zone (below 1.81).
Altman Z-score, annual
Embed this chart
Annual newest first
| Period | Altman Z-score | Change (points) |
|---|---|---|
| FY2025 | −0.87 | (0.77) |
| FY2024 | −0.10 | (2.87) |
| FY2023 | 2.77 | (4.95) |
| FY2022 | 7.72 | 3.57 |
| FY2021 | 4.15 | 1.14 |
| FY2020 | 3.01 | (0.20) |
| FY2019 | 3.20 | 1.91 |
| FY2018 | 1.29 | (0.77) |
| FY2017 | 2.07 | (0.45) |
| FY2016 | 2.51 | 0.35 |
How fiscal 2025’s score is made up
| Component | This year | Year before | Result | Points |
|---|---|---|---|---|
| Working capital / total assets | 0.25 | — | 0.30 | |
| Retained earnings / total assets | (1.63) | — | −2.28 | |
| EBIT / total assets | (0.31) | — | −1.03 | |
| Market value of equity / total liabilities | 2.07 | — | 1.24 | |
| Sales / total assets | 0.89 | — | 0.89 | |
| Altman Z-score | Distress zone | −0.87 | ||
| Z″ Variant for non-manufacturing and asset-light companies (drops the sales/assets term, uses book equity) | Distress zone | −5.40 | ||
How the Altman Z-score works
Z = 1.2 × working capital ÷ total assets + 1.4 × retained earnings ÷ total assets + 3.3 × EBIT ÷ total assets + 0.6 × market value of equity ÷ total liabilities + 1.0 × revenue ÷ total assets (Altman, 1968). The market value of equity is the close on the last trading day of the fiscal year times weighted basic shares.
Z″ = 6.56 × working capital ÷ total assets + 3.26 × retained earnings ÷ total assets + 6.72 × EBIT ÷ total assets + 1.05 × book equity ÷ total liabilities (Altman, Hartzell and Peck, 1995), the variant for non-manufacturing and asset-light companies.
| Zone | Z | Z″ |
|---|---|---|
| Safe zone | above 2.99 | above 2.60 |
| Grey zone | 1.81–2.99 | 1.10–2.60 |
| Distress zone | below 1.81 | below 1.10 |
Not worked out for banks, insurers and REITs, whose balance sheets the model does not describe, nor when a figure is missing or there is no share price in the week to the fiscal year end.
Altman Z-score against peers
| Company | Altman Z-score |
|---|---|
| AHG Akso Health Group Sponsored ADR compare | 113× |
| CAH Cardinal Health, Inc. compare | 5.1× |
| HKPD Cellyan Biotechnology Co., Ltd compare | 3.4× |
| YI 111, Inc. Sponsored ADR compare | 3.3× |
| HSIC Henry Schein, Inc. compare | 2.7× |
| ACH Accendra Health, Inc. compare | 0.4× |
| FOCL FocalTherics | −0.9× |
| COSM Cosmos Health Inc. compare | −2.5× |
| SNYRQ Synergy CHC Corp. compare | −7.0× |
What Altman Z-score is
The Altman Z-Score weighs working capital, retained earnings, operating profit, market value and sales against assets and debts to gauge the risk of distress.
1.2 × working capital ÷ total assets + 1.4 × retained earnings ÷ total assets + 3.3 × EBIT ÷ total assets + 0.6 × market value of equity ÷ total liabilities + 1.0 × revenue ÷ total assets